Schizophrenia Research and Treatment

Scope & Guideline

Exploring new frontiers in schizophrenia research.

Introduction

Explore the comprehensive scope of Schizophrenia Research and Treatment through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Schizophrenia Research and Treatment in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2090-2085
PublisherHINDAWI LTD
Support Open AccessYes
CountryEgypt
TypeJournal
Convergefrom 2014 to 2023
AbbreviationSCHIZOPHR RES TREAT / Schizophr. Res. Treat.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The journal 'Schizophrenia Research and Treatment' focuses on advancing the understanding and treatment of schizophrenia through rigorous research and clinical studies. Its aims encompass a variety of aspects related to the disorder, including pharmacological interventions, psychosocial factors, and the biological underpinnings of schizophrenia.
  1. Clinical and Pharmacological Research:
    The journal emphasizes studies examining the effectiveness, adherence, and side effects of pharmacological treatments, including typical and atypical antipsychotics.
  2. Psychosocial and Behavioral Factors:
    Research exploring the impact of psychosocial factors such as smoking, body composition, and suicide behavior on schizophrenia is a significant focus, highlighting the multifaceted nature of the disorder.
  3. Biochemical and Biological Investigations:
    The journal publishes studies that investigate biochemical markers and biological disturbances associated with schizophrenia, contributing to the understanding of its pathogenesis.
  4. Functional Outcomes and Quality of Life:
    Research on how various clinical characteristics and symptoms affect the functional outcomes and overall quality of life of patients with schizophrenia is a core area of interest.
Recent publications in 'Schizophrenia Research and Treatment' reveal several emerging themes that highlight the evolving landscape of schizophrenia research. These trends reflect a growing recognition of the complexity of the disorder and the need for comprehensive approaches to understanding and treating it.
  1. Impact of Physical Health on Schizophrenia:
    There is an increasing focus on the intersection of physical health, such as body mass index and smoking, and its implications for schizophrenia, emphasizing the holistic health needs of patients.
  2. Cultural and Regional Studies:
    Recent studies, particularly from diverse geographical locations like Uganda and Ethiopia, indicate a trend towards understanding schizophrenia within different cultural contexts, which may inform culturally sensitive treatment approaches.
  3. Exploration of Biochemical Markers:
    Emerging research on biochemical markers, such as homocysteine levels, suggests a trend towards elucidating the biological factors that may contribute to schizophrenia, potentially leading to novel therapeutic targets.

Declining or Waning

While the journal maintains a diverse range of topics related to schizophrenia, certain themes appear to be declining in prominence based on recent publications. This may reflect shifts in research focus or emerging priorities in the field.
  1. Traditional Psychotherapeutic Approaches:
    There has been a noticeable decrease in publications focusing on traditional psychotherapy methods for treating schizophrenia, possibly due to a growing emphasis on pharmacological and integrated treatment approaches.
  2. Longitudinal Studies on Schizophrenia Progression:
    Fewer longitudinal studies examining the long-term progression of schizophrenia have been published recently, suggesting a shift towards cross-sectional studies that provide immediate insights.

Similar Journals

Biological Psychiatry

Unraveling the complexities of psychiatric disorders through biology.
Publisher: ELSEVIER SCIENCE INCISSN: 0006-3223Frequency: 24 issues/year

Biological Psychiatry is a premier journal dedicated to advancing the understanding of the biological underpinnings of psychiatric disorders. Published by Elsevier Science Inc, this esteemed journal is recognized globally for its rigorous peer-reviewed research and contributes significantly to the field of biological psychiatry. With an impressive impact factor that places it in Q1 of its category and ranks 3rd out of 51 in Neuroscience Biological Psychiatry, it reflects the journal's strength in disseminating high-quality findings that push the boundaries of knowledge. Since its inception in 1969, the journal has undergone continuous evolution, aiming to integrate biological and clinical perspectives to optimize the understanding of mental health conditions. Although it does not offer open access, Biological Psychiatry serves as a critical resource for researchers, practitioners, and students, offering insights that influence both theoretical frameworks and practical applications in the realm of psychiatric science.

PSYCHIATRY AND CLINICAL NEUROSCIENCES

Illuminating the Pathways of Mental Health Research
Publisher: WILEYISSN: 1323-1316Frequency: 12 issues/year

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

SCHIZOPHRENIA BULLETIN

Empowering mental health professionals with cutting-edge knowledge.
Publisher: OXFORD UNIV PRESSISSN: 0586-7614Frequency: 6 issues/year

SCHIZOPHRENIA BULLETIN, published by Oxford University Press, stands as a leading journal in the field of psychiatry and mental health, particularly focusing on the complexities of schizophrenia. Established in 1973, this esteemed journal covers a wide spectrum of research areas, including clinical findings, neurobiology, epidemiology, and treatment approaches, making it indispensable for researchers and practitioners alike. With its current status in the Q1 category of the psychiatry and mental health disciplines, and a remarkable Scopus rank of #34 out of 567, the journal enjoys a strong impact factor, emphasizing its contribution to advancing knowledge in mental health. Although it operates on a subscription model, the significance of the journal in disseminating groundbreaking research makes it a vital resource for those committed to improving outcomes in schizophrenia. Through its rigorous peer-review process and commitment to high-quality scientific communication, SCHIZOPHRENIA BULLETIN continues to be at the forefront of psychiatric research and discourse.

General Psychiatry

Connecting researchers to reshape the future of psychiatry.
Publisher: BMJ PUBLISHING GROUPISSN: 2096-5923Frequency: 6 issues/year

General Psychiatry is a leading open-access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of psychiatry and mental health. With an impressive impact factor and ranked in the Q1 category across various related disciplines—including Psychiatry and Mental Health, as well as Clinical Neurology—this journal offers a vital platform for researchers and practitioners in the field to disseminate high-quality studies and insights. The journal has been open access since 2018, ensuring that the latest research is freely available to a global audience, thus fostering greater collaboration and innovation. With a focus on significant developments and emerging trends, General Psychiatry serves as an essential resource for professionals keen on improving mental health practices and understanding neurological aspects of mental disorders. The journal is based in the United Kingdom, reflecting a commitment to global health discussions and initiatives in psychiatry.

ACTAS ESPANOLAS DE PSIQUIATRIA

Shaping the future of psychiatry with impactful studies.
Publisher: JUAN JOSE LOPEZ-IBOR FOUNDATIONISSN: 1139-9287Frequency: 6 issues/year

ACTAS ESPANOLAS DE PSIQUIATRIA, published by the renowned JUAN JOSE LOPEZ-IBOR FOUNDATION, serves as a vital resource in the field of psychiatry and mental health, particularly within the Spanish-speaking academic community. With its ISSN 1139-9287 and E-ISSN 1578-2735, this journal has been a critical platform for disseminating high-quality research since its inception in 1996 and continues to contribute valuable insights until 2024. As a recognized journal in the Q3 category of psychiatry and mental health, it ranks 387 out of 567 in Scopus, placing it within the 31st percentile, thereby indicating a growing influence among its peers. The journal’s open access options enhance its accessibility, encouraging a broader readership to engage with contemporary research issues in mental health. Researchers, professionals, and students alike will find ACTAS ESPANOLAS DE PSIQUIATRIA essential for staying informed on the latest developments and innovations in psychiatric practice and research.

Revista de Psiquiatria y Salud Mental

Fostering Collaboration in Mental Health Science
Publisher: ELSEVIER ESPANA SLUISSN: 1888-9891Frequency: 4 issues/year

Revista de Psiquiatria y Salud Mental, published by ELSEVIER ESPANA SLU, stands as a pivotal resource in the field of Psychiatry and Mental Health. With an impressive impact factor and ranked in the Q2 category of its field, this journal aims to contribute significantly to the scientific discourse surrounding mental health issues. Since its inception in 2008, it has provided a platform for cutting-edge research, promoting knowledge sharing and collaboration among academics, clinicians, and practitioners dedicated to improving mental health outcomes. With comprehensive coverage from 2008 to 2023, this journal has also achieved commendable rankings in Scopus, placing it at #76 out of 531 in Psychiatry and Mental Health, reflecting its authoritative position within the scholarly community. As an Open Access journal, it embraces the ideals of accessibility and knowledge dissemination, ensuring that vital research reaches a wider audience. Researchers, professionals, and students alike will find the Revista de Psiquiatria y Salud Mental an invaluable resource for the latest studies, trends, and innovations in mental health.

Iranian Journal of Psychiatry and Behavioral Sciences

Bridging Gaps in Psychiatry and Behavioral Sciences
Publisher: BRIEFLANDISSN: 1735-8639Frequency: 4 issues/year

Iranian Journal of Psychiatry and Behavioral Sciences, published by BRIEFLAND, is a pivotal platform for scholars and practitioners in the fields of psychiatry and behavioral sciences. With its ISSN 1735-8639 and E-ISSN 1735-9287, this journal primarily caters to the Iranian context while fostering a global dialogue on contemporary issues in mental health, behavioral neurology, and biological psychiatry. Since its inception in 2007, the journal has committed to disseminating high-quality research and reviews, thereby contributing to its categorization in the fourth quartile (Q4) for both Behavioral Neuroscience and Biological Psychiatry as of 2023. Although currently lacking an open access model, the journal's accessibility to critical research discussions is vital for enhancing knowledge among researchers, professionals, and students alike. With emerging relevance in the Iranian mental health landscape, it aims to bridge gaps in understanding and promote evidence-based practices from 2007 to 2024 and beyond.

ACTA NEUROPSYCHIATRICA

Championing Excellence in Neuropsychiatric Research
Publisher: CAMBRIDGE UNIV PRESSISSN: 0924-2708Frequency: 6 issues/year

ACTA NEUROPSYCHIATRICA is a distinguished journal published by Cambridge University Press, covering essential research across the fields of psychiatry and neuroscience. Since its inception in 1989, it has become a pivotal resource for researchers and clinicians, providing a platform for the latest advancements and insights in biological psychiatry. With an impressive Scopus rank of #66 out of 567 in the Psychiatry and Mental Health category, and #10 out of 51 in Biological Psychiatry, the journal is recognized for its significant contributions to the field, boasting an 88th percentile ranking in overall impact. Although it operates under a traditional access model, the journal remains committed to disseminating high-quality research that addresses critical issues in mental health. Whether you are a professional seeking the latest findings or a student aiming to deepen your knowledge, ACTA NEUROPSYCHIATRICA is an indispensable resource for cutting-edge developments that shape our understanding of the human mind.

Brazilian Journal of Psychiatry

Transforming psychiatric practices through open access knowledge.
Publisher: ASSOC BRASILEIRA PSIQUIATRIAISSN: 1516-4446Frequency: 4 issues/year

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE

Advancing the Frontiers of Neurology and Psychiatry
Publisher: GEORG THIEME VERLAG KGISSN: 0720-4299Frequency: 12 issues/year

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE is a pivotal journal in the fields of neurology, psychiatry, and related medical disciplines, published by GEORG THIEME VERLAG KG in Germany. With a history dating back to 1955, this journal has evolved to address the dynamic nature of neurological and psychiatric research, offering valuable insights and advancements in the field. Despite holding a Q4 category status in various medical domains according to the 2023 quartiles, the journal continues to foster academic discussion and engagement among researchers and clinicians alike. It serves as a vital platform for disseminating knowledge through original research articles, reviews, and clinical studies, making it an essential resource for professionals and students aiming to stay abreast of the latest developments in mental health and neurological science. Although the journal currently does not offer open access options, its contribution to the academic community is significant, helping to illuminate the intricate relationships between neurological disorders and psychiatric conditions.